Dapivirine, a non-nucleoside reverse transcriptase inhibitor, is a potent and promising anti-HIV molecule. It is currently being investigated for use as a vaginal microbicide in two dosage forms, a semi-solid gel and a silicone elastomer ring. Quick-dissolving films are promising and attractive dosage forms that may provide an alternative platform for the vaginal delivery of microbicide drug candidates. Vaginal films may provide advantages such as discreet use, no product leakage during use, lack of requirement for an applicator for insertion, rapid drug release and minimal packaging and reduced wastage. Within this study the in vitro bioactivity of dapivirine as compared to the NNRTI UC781 was further established and a quick dissolve film was developed for vaginal application of dapivirine for prevention of HIV infection. The developed film was characterized with respect to its physical and chemical attributes including water content, mechanical strength, drug release profile, permeability, compatibility with lactobacilli and bioactivity. The anti-HIV activity of the formulated dapivirine film was confirmed in in vitro and ex vivo models. Importantly the physical and chemical properties of the film as well as its bioactivity were maintained for a period of 18 months. In conclusion, a vaginal film containing dapivirine was developed and characterized. The film was shown to prevent HIV-1 infection in vitro and ex vivo and have acceptable characteristics which make this film a promising candidate for testing as vaginal microbicide.
Dapivirine , a non - nucleoside reverse transcriptase inhibitor , is a potent and promising anti - HIV molecule . It is currently being investigated for use as a vaginal microbicide in two dosage forms , a semi - solid gel and a silicone elastomer ring . Quick - dissolving films are promising and attractive dosage forms that may provide an alternative platform for the vaginal delivery of microbicide drug candidates . Vaginal films may provide advantages such as discreet use , no product leakage during use , lack of requirement for an applicator for insertion , rapid drug release and minimal packaging and reduced wastage . Within this study the in vitro bioactivity of dapivirine as compared to the NNRTI UC781 was further established and a quick dissolve film was developed for vaginal application of dapivirine for prevention of HIV infection . The developed film was characterized with respect to its physical and chemical attributes including water content , mechanical strength , drug release profile , permeability , compatibility with lactobacilli and bioactivity . The anti - HIV activity of the formulated dapivirine film was confirmed in in vitro and ex vivo models . Importantly the physical and chemical properties of the film as well as its bioactivity were maintained for a period of 18 months . In conclusion , a vaginal film containing dapivirine was developed and characterized . The film was shown to prevent HIV-1 infection in vitro and ex vivo and have acceptable characteristics which make this film a promising candidate for testing as vaginal microbicide .
Which infection can be prevented with Dapivirine?
Which infection can be prevented with Dapivirine ?
HIV
HIV